Current Developments in Genomics and Personalized Health Care: Impact on Public Health

被引:2
作者
Manamperi, Aresha [1 ]
机构
[1] Univ Kelaniya, Mol Med Unit, Fac Med, Ragama, Sri Lanka
关键词
human genome project; genomic medicine; personalized health care; biomarkers; microarrays; bioinformatics;
D O I
10.1177/1010539508316783
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The knowledge gained from the characterization of genomes, especially the human genome, holds considerable potential for the development of new health care innovations for prevention, diagnosis, and management of many diseases in the coming decade. However, owing to the presence of highly complex scientific, economic, social, and ethical issues associated with this field, societies will need to be better prepared for the era of postgenomics and its consequences. It is important to ensure that the benefits of genomics are distributed fairly among all the countries of the world and that the well-tried and more conventional approaches to medical research and practice are not neglected while the medical potential of genomics is being explored. In this report, the author focuses mainly on human genomics, its applications, development of related technologies and issues related to the dissemination of knowledge derived from genome information, and finally, their impact on global health care.
引用
收藏
页码:242 / 250
页数:9
相关论文
共 28 条
[1]   A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance [J].
Baier, LJ ;
Permana, PA ;
Yang, XL ;
Pratley, RE ;
Hanson, RL ;
Shen, GQ ;
Mott, D ;
Knowler, WC ;
Cox, NJ ;
Horikawa, Y ;
Oda, N ;
Bell, GI ;
Bogardus, C .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (07) :R69-R73
[2]   Genetic test evaluation: Information needs of clinicians, policy makers, and the public [J].
Burke, W ;
Atkins, D ;
Gwinn, M ;
Guttmacher, A ;
Haddow, J ;
Lau, J ;
Palomaki, G ;
Press, N ;
Richards, CS ;
Wideroff, L ;
Wiesner, GL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (04) :311-318
[3]  
*CDCP OFF GEN DIS, GEN WORKF COMP 2001
[4]   A vision for the future of genomics research [J].
Collins, FS ;
Green, ED ;
Guttmacher, AE ;
Guyer, MS .
NATURE, 2003, 422 (6934) :835-847
[5]   Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].
Druker, BJ ;
Lydon, NB .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7
[6]   APPLICATION OF THE 3-DIMENSIONAL STRUCTURES OF PROTEIN TARGET MOLECULES IN STRUCTURE-BASED DRUG DESIGN [J].
GREER, J ;
ERICKSON, JW ;
BALDWIN, JJ ;
VARNEY, MD .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) :1035-1054
[7]   Plasmodium, human and Anopheles genomics and malaria [J].
Hoffman, SL ;
Subramanian, GM ;
Collins, FH ;
Venter, JC .
NATURE, 2002, 415 (6872) :702-709
[8]   Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus [J].
Horikawa, Y ;
Oda, N ;
Cox, NJ ;
Li, XQ ;
Orho-Melander, M ;
Hara, M ;
Hinokio, Y ;
Lindner, TH ;
Mashima, H ;
Schwarz, PEH ;
del Bosque-Plata, L ;
Horikawa, Y ;
Oda, Y ;
Yoshiuchi, I ;
Colilla, S ;
Polonsky, KS ;
Wei, S ;
Concannon, P ;
Iwasaki, N ;
Schulze, T ;
Baier, LJ ;
Bogardus, C ;
Groop, L ;
Boerwinkle, E ;
Hanis, CL ;
Bell, GI .
NATURE GENETICS, 2000, 26 (02) :163-175
[9]   Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603
[10]   Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs [J].
Jomaa, H ;
Wiesner, J ;
Sanderbrand, S ;
Altincicek, B ;
Weidemeyer, C ;
Hintz, M ;
Türbachova, I ;
Eberl, M ;
Zeidler, J ;
Lichtenthaler, HK ;
Soldati, D ;
Beck, E .
SCIENCE, 1999, 285 (5433) :1573-1576